Divi's Laboratories Limited

Healthcare|Nifty100

DIVISLAB-EQ: NSEBSE: 10940

Divi's Laboratories Limited (DIVISLAB-EQ) live share price today at NSE / BSE

INR 9,323.00

+165.00 (1.8%)1 Day

Thu, 17 Sept 2026, 01:42 PM

About DIVISLAB-EQ

Divis Laboratories Ltd is a leading Indian pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients. Headquartered in Hyderabad, the company operates large-scale manufacturing facilities in Andhra Pradesh and Telangana, with a global footprint spanning over 100 countries. Established in 1990, Divis is known for its strong chemistries, process innovation, and focus on custom synthesis and contract manufacturing for major pharmaceutical companies worldwide.

52 Week Range

HighINR 9,615.00

LowINR 5,636.50

Current Signal

green

Open

INR 9,158.00

High

INR 9,371.00

Low

INR 9,135.50

Prev. Close

INR 9,158.00

Volume

4,94,167

Avg. Volume (7D)

5,48,601

Avg. Volume (10D)

5,08,184

Latest Signal

Buy

Buy Price

INR 9167.6

Close Price

INR 9323.0

Change

2.22%

Stoploss

INR 8892.6

Signal Date

2026-09-17

Hold

Yes

Pattern

Morning Star

Company Snapshot

CIN	L24110TG1990PLC011854
Industry	Pharmaceuticals
Market Lot	1
Impact Cost	0.03%
Listing Date	11 Mar 2003
BC Record Date	RD 25/07/2025
Registered Address	1-72/23(P)/DIVIS/303, Divi Towers, Cyber Hills, Gachibowli
Auditor	Price Waterhouse Chartered Accountants LLP

Registrar

Name

KFin Technologies Ltd

Telephone

040 - 67161526 / 18003094001

Website

www.kfintech.com

Shareholding Pattern

Quarterly filing · 30 Jun 2026

Promoter & Promoter Group51.88%

Non-Institutions10.09%

Domestic Institutions5.06%

Board of Directors

LKishoreBabuChief Financial Officer

Mr.DEVENDRA RAO SUREDDYExecutive Director

Mr.GANAPATY SERUNon-Executive - Independent Director

Mr.M. Satish ChoudhuryCompany Secretary & Compliance Officer

Mr.MURALI KRISHNA PRASAD DIVIExecutive Director-MD

Mr.NIMMAGADDA VENKATA RAMANAExecutive Director

Mr.RAJENDRA KUMAR PREMCHANDNon-Executive - Independent Director

Mr.RAMESHBABU VENKATA NIMMAGADDANon-Executive - Independent Director-Chairperson

Mr.SATCHANDRA KIRAN DIVIExecutive Director-CEO

Mr.VEERAYYA CHOWDARY KOSARAJUNon-Executive - Independent Director

Ms.NILIMA PRASAD DIVIExecutive Director

Ms.SUNAINA SINGHNon-Executive - Independent Director

Today Share Price

Divi's Laboratories Limited

Particulars	Details
Opening Price	INR 9,158.00
Previous Closing Price	INR 9,158.00
Volume of Divi's Laboratories Limited	4,94,167
Value of Share	—

Today NSE Share Price

Divi's Laboratories Limited

Particulars	Details
Live Share Price NSE India	INR 9,323.00
Previous Closing Price	INR 9,158.00
Open Price	INR 9,158.00
High	INR 9,371.00
Low	INR 9,135.50

Today BSE Share Price

Divi's Laboratories Limited

Particulars	Details
Live Share Price BSE India	INR 9,323.00
Previous Closing Price	INR 9,158.00
Open Price	INR 9,158.00
High	INR 9,371.00
Low	INR 9,135.50

Divi's Laboratories Limited

The company maintains a concentrated focus on complex APIs, especially in therapies such as neurology, anti-inflammatories, antihistamines, and cardiovascular agents. Divis Laboratories consistently invests in research and development, in-house technology platforms, and green chemistry processes, which underpin its reputation for regulatory compliance with US FDA, EDQM, and other global agencies. Its diversified clientele includes major global pharma innovators and generic companies.

Frequently Asked Questions – StockYaari Stock Page

Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.

Final Thoughts

Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.